ingredient intended to affect normal structure or function in the body. For example, a claim stating that calcium contributes to the maintenance of normal bones is a structure/function claim.

On the other hand, disease claims refer to statements that explicitly or implicitly suggest that a product can diagnose, cure, mitigate, treat, or prevent a disease. An example would be a claim such as “helps reduce the risk of osteoporosis.” Such claims fall under more stringent regulatory scrutiny because they imply therapeutic benefits.

Regulatory Framework in the United States

In the United States, the FDA oversees dietary supplement regulation, primarily under the Dietary Supplement Health and Education Act (DSHEA) of 1994. The DSHEA allows manufacturers to make structure/function claims, provided the claims are substantiated and disclaimer language accompanies them. Manufacturers must notify the FDA of their claims within 30 days of marketing the product, which is a critical step in maintaining compliance.

Structuring a claim requires that it does not suggest that the product can treat or prevent disease. Therefore, a detailed understanding of the FDA’s regulations regarding claim substantiation is crucial.

Claim Substantiation Requirements

• Scientific Evidence: Manufacturers must have adequate evidence to substantiate claims made. This includes scientific studies and data that support the effect of the nutrient or ingredient on structure and function.
• Labeling Requirements: Any structure/function claims must include a disclaimer stating that the FDA has not evaluated the claim.
• FDA Notification: Initial claim notification must be sent to the FDA; failure to do so can lead to warning letters and potential regulatory action. Regular monitoring of FDA scrutiny and guidance related to structure/function claims is recommended.

Regulatory Oversight in the European Union

In contrast, dietary supplement marketing in the EU is governed by EU legislation, primarily Regulation (EC) No 1924/2006 on Nutrition and Health Claims Made on Foods. EFSA is responsible for scientific evaluation, and thus any health claims, including structure/function claims, must be substantiated based on scientific evidence. Interstitial variation exists, where Health Claims made on supplements in Member States may differ in applicability and acceptability.

Notably, a significant difference in the regulatory approach is that all health claims in the EU must be authorized before use, contrasting with the more lenient approach seen in the U.S.

Key Regulatory Differences

• Pre-Market Authorization: Unlike in the U.S., all health claims require EFSA approval prior to use in marketing and labeling.
• Criteria for Evidence: EFSA has more rigid standards for claim substantiation, requiring systematic reviews and meta-analyses to substantiate claims.
• Defined Claims List: EFSA maintains a register of approved claims, limiting the claims that can be used unless specifically listed.

Structure/Function Claims in Detail

To navigate structure/function claims effectively in both the U.S. and Europe, professionals must understand the specific requirements that govern how claims can be framed. In the U.S., structure/function claims must clearly state the intended effect of the nutrient or ingredient, while avoiding any implications of disease treatment or prevention. In practice, this means that wording must be carefully selected to convey only the intended function.

For instance, a claim stating “supports immune health” is acceptable as a structure/function claim in the U.S., while stating “prevents the flu” crosses into disease claim territory and is not permissible without FDA approval.

In the EU, structure/function claims are similarly scrutinized. However, the European Food Safety Authority requires manufacturers to align their claims strictly with established scientific evidence. Companies must submit comprehensive documentation demonstrating that their claims are not only scientifically vetted but also comply with the authorized claims list.

Steps to Prepare Structure/Function Claims

• Identify the Claim: Determine the intended structure/function claim while ensuring it does not imply disease prevention.
• Gather Evidence: Collect scientific studies and other evidence that demonstrate the effect of the dietary ingredient.
• Draft the Claim: Construct the claim in compliance with regulatory language guidelines.
• Document Submission: For U.S. businesses, submit the necessary notifications to the FDA within the allotted time frame.
• Monitor Regulatory Changes: Regularly review FDA and EFSA updates on claim regulations to ensure ongoing compliance.

Disease Claims and Their Implications

Claiming that a dietary supplement can treat or prevent disease falls under rigorous regulations in both regions. The FDA does not allow any dietary supplements to be marketed with disease claims unless the product is classified as a drug and goes through the New Drug Application (NDA) process. This distinction is crucial for ensuring compliance and avoiding warning letters from the FDA.

In the EU, the same principles apply; however, defining what qualifies as a disease claim can be somewhat flexible, leading to potential gray areas that practitioners must navigate carefully. The very act of linking a dietary ingredient to health can invoke scrutiny in the EU. The strictness emphasizes the need for precise language and unequivocal scientific backing.

Comparative Challenges in Claim Substantiation

• Research-Driven Evidence: Due to differing standards and expectations, companies may find it more challenging to substantiate claims in the EU compared to the U.S.
• Language and Context: The contextual use of terms can lead to confusion over what constitutes an acceptable claim; what is permissible in one jurisdiction may not be so in another.
• Regulatory Engagement: Active engagement with both FDA and EFSA may aid companies in testing the waters of claim applications for better alignment with compliance requirements.

Navigating Marketing Reviews and Warning Letters

Marketing reviews are essential to ensuring compliance, as they serve as a preemptive measure against receiving warning letters from regulatory bodies. In the U.S., the FDA regularly issues warning letters regarding unsubstantiated claims made in advertising and labeling, particularly for those that traverse into the territory of disease claims. Recognizing the signs of potential regulatory action can be crucial for companies seeking to navigate the complex landscape of dietary supplement marketing.

Understanding common pitfalls associated with **FDA claim rules** helps reduce the risk of regulatory action. Some prevalent issues include:

• Adequate scientific substantiation for claims.
• Failure to notify the FDA of claims made.
• Using vague or misleading language in advertising material.

Regularly conducting marketing reviews ensures that claims remain compliant with the current expectations of the FDA while also preparing for potential inquiries from European authorities. Tracking the landscape can shield companies from liability associated with regulatory noncompliance.

Conclusion

Understanding the differences between structure/function claims and disease claims in dietary supplements is paramount for regulatory, QA, QC, and compliance professionals. The regulatory frameworks established by the FDA and EFSA involve different requirements for substantiation and oversight. Thus, it is critical to have a robust internal compliance system in place that monitors claims made on products consistently.

By following the outlined steps to navigate these complex regulations and maintaining awareness of the evolving landscape, professionals can position their brands confidently within both the U.S. and EU markets. This ensures not only legal compliance but also reinforces the marketing credibility of dietary supplements on a global scale.